NASDAQ:TNFA

TNF Pharmaceuticals (TNFA) Stock Price, News & Analysis

TNF Pharmaceuticals logo
$0.30 -0.01 (-3.36%)
As of 11/19/2026

About TNF Pharmaceuticals Stock (NASDAQ:TNFA)

Advanced

Key Stats

Today's Range
$0.29
▼
$0.32
50-Day Range
$0.30
▼
$1.71
52-Week Range
$0.04
▼
$8.94
Volume
112,200 shs
Average Volume
32.22 million shs
Market Capitalization
$546.71 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

TNF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments that target tumor necrosis factor (TNF) and related inflammatory pathways. Its research has included potential therapies for inflammatory and fibrotic conditions.

The company’s development programs have addressed conditions such as Dupuytren’s disease, which causes thickening of tissue in the hand, and frozen shoulder. These programs are investigational and are not established treatments.

TNF Pharmaceuticals was formerly known as 180 Life Sciences Corp. and adopted its current name in 2024 to reflect its focus on TNF-related drug development.

AI Generated. May Contain Errors.

Receive TNFA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TNF Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TNFA Stock News Headlines

Why did QCLS stock surge over 60% today?
Beyond NVDA: The World’s Next #1 Company?
This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvidia's. A NASA scientist says the technology behind it is bigger than AI. Musk calls it "Amazing," and a Nobel Prize winner describes its power as "unprecedented in the history of life on Earth." Adam O'Dell, Chief Investment Strategist at Money and Markets, names the company at the center of it all.tc pixel
See More Headlines

TNFA Stock Analysis - Frequently Asked Questions

TNF Pharmaceuticals' stock was trading at $3.99 at the start of the year. Since then, TNFA shares have decreased by 92.6% and is now trading at $0.2960.

TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) released its quarterly earnings data on Tuesday, August, 19th. The company reported ($18.00) earnings per share for the quarter.

TNF Pharmaceuticals shares reverse split on the morning of Tuesday, September 2nd 2025.The 1-100 reverse split was announced on Thursday, August 28th 2025. The number of shares owned by shareholders was adjusted after the market closes on Friday, August 29th 2025. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Shares of TNFA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that TNF Pharmaceuticals investors own include Biopharmx (BPMX), Advanced Micro Devices (AMD), Jaguar Animal Health (JAGX), Remark (MARK), Aytu BioPharma (AYTU), XTI Aerospace (XTIA) and Top Ships (TOPS).

Company Calendar

Today
11/20/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Technology Hardware, Storage & Peripherals
Sub-Industry
Technology Hardware, Storage & Peripherals
Current Symbol
NASDAQ:TNFA
Previous Symbol
NASDAQ:MYMD
CIK
1321834
Employees
6
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($231.00)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$23.36 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-69.21%
Return on Assets
-33.98%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.93
Quick Ratio
0.93

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$286.76 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
1,847,000
Free Float
1,839,000
Market Cap
$546.71 thousand
Optionable
N/A
Beta
2.04
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NASDAQ:TNFA) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners